Physician profile
Awaneesh Kumar
NPI 1427557099
$68,351.36
in general payments reported to CMS, 2019-2025
25 companies · $64K in 2025
The $64K reported for 2025 was more than what 99% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $875 · 2022: $1,610 · 2023: $1,189 · 2024: $1,125 · 2025: $64K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $55K · Food and Beverage: $5,618 · Travel and Lodging: $4,619 · Education: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $55,000.00 |
| Food and Beverage | $5,617.61 |
| Travel and Lodging | $4,619.13 |
| Education | $629.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $23,699.13 | 2025 | General - Ep, General - Therapies, Farapulse |
| Medtronic, INC. | $20,614.54 | 2022-2025 | Micra, Turbohawk, Onyx Frontier |
| Abbott Laboratories | $16,502.97 | 2021-2025 | Assurity, Tacticath, Ensite |
| Biotronik INC. | $2,602.93 | 2025 | Renamic Neo |
| Biosense Webster, INC. | $1,466.19 | 2025 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $1,136.03 | 2021-2025 | Lifevest |
| Inari Medical, INC. | $585.13 | 2023-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Actelion Pharmaceuticals US, INC. | $444.00 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $302.90 | 2022-2024 | Xarelto |
| Abiomed | $296.23 | 2022-2024 | Impella |
| Astrazeneca Pharmaceuticals LP | $215.48 | 2021-2022 | |
| Cardiovascular Systems INC. | $132.74 | 2021-2023 | Diamondback Peripheral |
| Merck Sharp & Dohme LLC | $71.97 | 2023-2024 | Verquvo |
| Alnylam Pharmaceuticals INC. | $55.15 | 2023 | Amvuttra |
| Teleflex LLC | $26.39 | 2023 | Guideliner, Turnpike |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Getinge USA Sales, LLC | $25.49 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $24.06 | 2025 | Evkeeza |
| Genzyme Corporation | $22.44 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $21.55 | 2022 | |
| Siemens Medical Solutions USA, INC. | $20.97 | 2022 | |
| Opsens INC. | $20.94 | 2022 | |
| Cardiva Medical, INC. | $17.65 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Terumo Medical Corporation | $17.27 | 2024 | Tr Band, Angio-Seal |
| Scpharmaceuticals INC. | $15.16 | 2023 | |
| Lexicon Pharmaceuticals, INC. | $14.05 | 2023 | Inpefa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Awaneesh Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.